Five Prime Therapeutics, Inc. logo
Five Prime Therapeutics, Inc. FPRX
$ 38.0 0.0%

Five Prime Therapeutics, Inc. Financial Statements 2011-2024 | FPRX

Annual Financial Statements Five Prime Therapeutics, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

616 M 169 M 384 M 584 M 1.19 B 923 M 549 M 82.5 M - -

Shares

36.8 M 35 M 34 M 27.9 M 27 M 25.7 M 20.9 M 5.52 M - -

Net Income

-84.3 M -137 M -140 M -150 M -65.7 M 250 M -37.4 M -28.9 M -27.6 M 19.7 M

Revenue

13.2 M 14.9 M 49.9 M 39.5 M 30.7 M 380 M 19.2 M 13.8 M 9.98 M 64.9 M

EBITDA

-87 M -137 M -141 M -149 M -97.5 M 289 M -36 M -27.7 M -26.2 M 21.3 M

Operating Expenses

106 M 157 M 196 M 191 M 130 M 92.8 M 56.8 M 43.2 M 37.8 M 45.3 M

General and Administrative Expenses

40.6 M 42.7 M 39.7 M 40 M 35.8 M 22.6 M 13.6 M 10.4 M 9.01 M 11.2 M

All numbers in USD currency